Electronic prescribing was designed to move prescriptions from point A to point B, not to give patients the information they need to pick those points on the spot. Photon just raised $16M in Series A funding to fill the gap.
Photon got its start in 2021 building prescription infrastructure for direct-to-consumer telehealth companies, powering some of the fastest-growing brands of the pandemic and GLP-1 era.
That experience provided a solid foundation. Photon built deep integrations across pharmacy networks, real-time formulary data, and a patient-first prescribing experience.
- That foundation not only proved compelling to DTC startups, but also to health systems looking for better ways to engage patients at the point of care and drive visibility into their in-house pharmacies.
- Fast forward to the Series A, and Photon is leaning in on the enterprise market where it can make the biggest impact.
Photon isn’t a pricing widget. It’s an end-to-end platform that includes:
- Modern prescribing and routing infrastructure
- A network of pharmacy partners across retail and home delivery
- A consumer-facing marketplace that surfaces real-time price and stock information
- A full suite of capabilities including prior auths and clinical decision support
AI underpins everything. Photon’s AI ingests fragmented data across pharmacy networks, benefit structures, and formularies, then translates it into info that patients can actually use.
- That gives patients a sense of what’s convenient, what’s covered, what delivery options are available, and most importantly – price.
- Put it all together, and patients can make informed choices before prescriptions ever get sent.
Health systems get something equally valuable. The prescription becomes a patient engagement touchpoint instead of a handoff.
- In-house pharmacy teams gain real-time visibility into fill activity, and having patients that are actually informed results in fewer abandoned scripts, less reroutes, and a meaningfully better experience for everyone involved.
The Takeaway
Right when healthcare services are getting disrupted by LLMs and agents, patients are hitting a boiling point with affordability and transparency. The pharmacy experience is a major intersection for both roads, and Photon just raised $16M to modernize all four corners.
